Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 736 AL 750

Parkinsonism in the psychiatric setting: an update on clinical differentiation and management

Powell A, Gallur L, Koopowitz L, Hayes MW.

BMJ Neurol Open. 2020 Jan 27;2(1):e000034. doi: 10.1136/bmjno-2019-000034. eCollection 2020.

A Recent Look into Natural Products that have Potential to Inhibit Cholinesterases and Monoamine Oxidase B: Update for 2010-2019

Gulcan HO, Orhan IE.

Comb Chem High Throughput Screen. 2020;23(9):862-876. doi: 10.2174/1386207323666200127145246.

Protein Quality Control Pathways at the Crossroad of Synucleinopathies

De Mattos EP, Wentink A, Nussbaum-Krammer C, Hansen C, Bergink S, Melki R, Kampinga HH.

J Parkinsons Dis. 2020;10(2):369-382. doi: 10.3233/JPD-191790.

Patient-controlled variable dosing of levodopa for Parkinson's disease

Roycroft M, Abdelhafiz AH, Rose J.

Age Ageing. 2020 Feb 27;49(2):305-306. doi: 10.1093/ageing/afz167.

If not salivary alpha-synuclein, then what? A look at potential Parkinson's disease biomarkers

Bougea A.

Expert Rev Mol Diagn. 2020 Apr;20(4):359-361. doi: 10.1080/14737159.2020.1721283. Epub 2020 Jan 27.

Misconnecting the dots: altered mitochondrial protein-protein interactions and their role in neurodegenerative disorders

Zilocchi M, Moutaoufik MT, Jessulat M, Phanse S, Aly KA, Babu M.

Expert Rev Proteomics. 2020 Feb;17(2):119-136. doi: 10.1080/14789450.2020.1723419. Epub 2020 Feb 6.

Changes in Parkinsonian gait kinematics with self-generated and externally-generated cues: a comparison of responders and non-responders

Harrison EC, Horin AP, Myers PS, Rawson KS, Earhart GM.

Somatosens Mot Res. 2020 Mar;37(1):37-44. doi: 10.1080/08990220.2020.1713740. Epub 2020 Jan 27.

Fatty acid metabolism in the progression and resolution of CNS disorders

Bogie JFJ, Haidar M, Kooij G, Hendriks JJA.

Adv Drug Deliv Rev. 2020;159:198-213. doi: 10.1016/j.addr.2020.01.004. Epub 2020 Jan 25.

Using curcumin to turn the innate immune system against cancer

Mukherjee S, Baidoo JNE, Fried A, Banerjee P.

Biochem Pharmacol. 2020 Jun;176:113824. doi: 10.1016/j.bcp.2020.113824. Epub 2020 Jan 24.

Endoplasmic reticulum stress, an important factor in the development of Parkinson's disease

Mou Z, Yuan YH, Zhang Z, Song LK, Chen NH.

Toxicol Lett. 2020 May 15;324:20-29. doi: 10.1016/j.toxlet.2020.01.019. Epub 2020 Jan 24.

Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays

Candelise N, Schmitz M, Thüne K, Cramm M, Rabano A, Zafar S, Stoops E, Vanderstichele H, Villar-Pique A, Llorens F, Zerr I.

Transl Neurodegener. 2020 Jan 17;9:5. doi: 10.1186/s40035-019-0181-9. eCollection 2020.

[Delirium in idiopathic Parkinson's disease]

Franke C, Ebersbach G.

Nervenarzt. 2020 Feb;91(2):107-113. doi: 10.1007/s00115-020-00876-2.

Parkinson's disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia

De Rui M, Inelmen EM, Trevisan C, Pigozzo S, Manzato E, Sergi G.

Aging Clin Exp Res. 2020 Jul;32(7):1211-1218. doi: 10.1007/s40520-020-01470-x. Epub 2020 Jan 27.

Alzheimer's Disorder: Epigenetic Connection and Associated Risk Factors

Sharma VK, Mehta V, Singh TG.

Curr Neuropharmacol. 2020;18(8):740-753. doi: 10.2174/1570159X18666200128125641.

The contribution of Parkin, PINK1 and DJ-1 genes to selective neuronal degeneration in Parkinson's disease

van der Vlag M, Havekes R, Heckman PRA.

Eur J Neurosci. 2020 Aug;52(4):3256-3268. doi: 10.1111/ejn.14689. Epub 2020 Feb 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias